US · Healthcare

Kaleido Biosciences Inc (KLDO)

Biotechnology

Kaleido Biosciences Inc (KLDO) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for KLDO

P/E ratio

18.00

Kaleido Biosciences Inc (KLDO) — FAQ

What is KLDO's P/E ratio?

The price-to-earnings (P/E) ratio for Kaleido Biosciences Inc (KLDO) is 18.00 (data as of 2026-03-24).

Does Kaleido Biosciences Inc pay a dividend?

Dividend yield is not available in the current snapshot for Kaleido Biosciences Inc (KLDO). Check the MyAverix Finance app for the latest dividend data.

What sector is Kaleido Biosciences Inc in?

Kaleido Biosciences Inc (KLDO) is classified in the Healthcare sector (Biotechnology industry).

What exchange is KLDO listed on?

KLDO is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)